Strategic Investment Solutions’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343 Hold
25
﹤0.01% 652
2026
Q1
$151 Hold
25
﹤0.01% 651
2025
Q4
$180 Hold
25
﹤0.01% 604
2025
Q3
$268 Hold
25
﹤0.01% 571
2025
Q2
$243 Hold
25
﹤0.01% 569
2025
Q1
$373 Hold
25
﹤0.01% 583
2024
Q4
$368 Buy
25
+1
+4% +$16 ﹤0.01% 602
2024
Q3
$464 Buy
24
+3
+14% +$62 ﹤0.01% 574
2024
Q2
$672 Buy
+21
New +$417 ﹤0.01% 550
2023
Q4
$336 Sell
23
-1,426
-98% -$19.4K ﹤0.01% 1071
2023
Q3
$29.7K Buy
1,449
+1,427
+6,486% +$29.8K ﹤0.01% 631
2023
Q2
$437 Sell
22
-210
-91% -$4.57K ﹤0.01% 816
2023
Q1
$5.46K Buy
+232
New +$6.23K ﹤0.01% 744

Other funds holding OGN

Strategic Investment Solutions's OGN Position: Q2 2026 in Review

Strategic Investment Solutions held its Organon & Co (OGN) position steady in Q2 2026 at 25 shares worth $343. The position accounts for ﹤0.01% of the portfolio, ranked #652.

Strategic Investment Solutions first reported a position in OGN in Q1 2023 and has held it in 13 quarters since. The position peaked at $29.7K in Q3 2023. 115 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Strategic Investment Solutions held 25 shares of Organon & Co worth $343 as of Q2 2026.
  • Strategic Investment Solutions left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Strategic Investment Solutions's portfolio in Q2 2026, its #652 holding.
  • Strategic Investment Solutions first reported a position in Organon & Co in Q1 2023 and has held it in 13 quarters since.
  • Strategic Investment Solutions's Organon & Co position peaked at $29.7K in Q3 2023.
  • 115 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Strategic Investment Solutions's 13F filing for Q2 2026, filed 8 Jul 2026.